CLINICAL_TRIALS
trial_result
· 2016-03-22
Clinical Trial Update: Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation [Phase 3]
Summary
A Phase 3 open-label trial evaluating Anascorp for scorpion sting envenomation in pediatric patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Scorpion Sting | Phase 3 | Status: COMPLETED